[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.161.30. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
July 2003

Cognitive Decline in Down Syndrome

Arch Neurol. 2003;60(7):1024. doi:10.1001/archneur.60.7.1024-a

We would like to congratulate Lott et al1 for their interesting article regarding the potential value of acetylcholinesterase inhibitors for the treatment of dementia in people with Down syndrome (DS). Dementia is increasingly common in DS, with 25% to 35% of the DS population aged 50 to 60 years being affected2,3; however, research on therapeutic interventions for dementia in this group remains sparse.

First Page Preview View Large
First page PDF preview
First page PDF preview
×